GLP-1 Drugs Tied to Smell, Taste Changes - Top-Institutions - MDSpire

GLP-1 Drugs Tied to Smell, Taste Changes

A matched electronic health record study of more than 876,000 patients with type 2 diabetes found a low absolute incidence but higher relative hazard of documented smell and taste disturbances among patients prescribed glucagon-like peptide-1 receptor agonists.

  • By

  • Andrea Surnit

  • June 27, 2026

  • 5 min

Share

Top Institutions in Otolaryngology

Brief introduction explaining scope and methodology.

  • #1

    Hadassah Medical Center
    Hadassah Medical Center

    Jerusalem, Israel

    Key Differentiators

    • Endocrinology

  • #2

    Hebrew University
    Hebrew University

    Jerusalem, Israel

    Key Differentiators

    • Endocrinology

  • #3

    Boston University Chobanian & Avedisian School of Medicine
    Boston University Chobanian & Avedisian School of Medicine

    Boston, Massachusetts

    Key Differentiators

    • Endocrinology

  • #4

    Ochsner Clinic Foundation
    Ochsner Clinic Foundation

    New Orleans, Louisiana

    Key Differentiators

    • Endocrinology

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Endocrinology

Original Source(s)

GLP-1 Drugs Tied to Smell, Taste Changes

  • by Andrea Surnit

  • June 27, 2026

Related Content

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.